Institutional investors purchased a net $3.5 million shares of ABMD during the quarter ended March 2014 and now own 108.39% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APEX CAPITAL MANAGEMENT, INC. Bought 19.3 Thousand shares of Abiomed Inc
SEI INVESTMENTS MANAGEMENT CORP. Bought 3.2 Thousand shares of Abiomed Inc